Attenuated expression of HRH4 in colorectal carcinomas: A potential influence on tumor growth and progression

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Fang, Zhengyu ^a   Yao, Wantong ^b   Xiong, Yi ^a   Li, Jiana ^a   Liu, Li ^a   Shi, Lei ^d   Zhang, Wei ^c,d   Zhang, Chao ^a   Nie, Liping ^e   Wan, Jun ^a,d  

^a Biomedical Research Institute   (China)

^b FUDAN UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

^d HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^e PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; FLUOROURACIL; HISTAMINE; HISTAMINE H4 RECEPTOR; ANTINEOPLASTIC ANTIMETABOLITE; CELL CYCLE PROTEIN; CLOBENPROPIT; DRUG DERIVATIVE; G PROTEIN COUPLED RECEPTOR; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; HRH4 PROTEIN, HUMAN; IMIDAZOLE DERIVATIVE; MESSENGER RNA; THIOUREA;

ADVANCED CANCER; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE REGULATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; EARLY CANCER; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; CELL CYCLE; CELL PROLIFERATION; COLORECTAL TUMOR; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FLUOROURACIL; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTAMINE H3 ANTAGONISTS; HUMANS; IMIDAZOLES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIOUREA;

EID: 79956282000     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-195     Document Type: Article

References (37)

1. Yang X, Wan DS. [Roles of insulin-like growth factor system in colorectal carcinoma and its applications]. Ai Zheng 2005, 24:1161-1164.
2. Collins TS, Hurwitz HI. Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer. Semin Oncol 2005, 32:61-68.
3. Guba M, Seeliger H, Kleespies A, Jauch KW, Bruns C. Vascular endothelial growth factor in colorectal cancer. Int J Colorectal Dis 2004, 19:510-517.
4. Venook AP. Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma. Cancer 2005, 103:2435-2446.
5. Kurtin SE. Targeting the epidermal growth factor receptor in colorectal carcinoma. Cancer Nurs 2007, 30:S1-9.
6. Yarom N, Jonker DJ. The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancer. Discov Med 11:95-105.
7. Medina MA, Quesada AR, Nunez de Castro I, Sanchez-Jimenez F. Histamine, polyamines, and cancer. Biochem Pharmacol 1999, 57:1341-1344.
8. Suonio E, Tuomisto L, Alhava E. Effects of histamine, H1, H2 and Hic receptor antagonists and alpha-fluoromethylhistidine on the growth of human colorectal cancer in the subrenal capsule assay. Agents Actions 1994, 41(Spec No):C118-120.
9. Masini E, Fabbroni V, Giannini L, Vannacci A, Messerini L, Perna F, Cortesini C, Cianchi F. Histamine and histidine decarboxylase up-regulation in colorectal cancer: correlation with tumor stage. Inflamm Res 2005, 54(Suppl 1):S80-81.
10. Hellstrand K, Brune M, Mellqvist UH, Naredi P. Histamine, cimetidine and colorectal cancer. Nat Med 1996, 2:364-365.
11. Molnar EL, Cricco G, Martin G, Darvas Z, Hegyesi H, Fitzsimons C, Bergoc R, Falus A, Rivera E. Histamine as a potential autocrine regulator of melanoma. Inflamm Res 2001, 50(Suppl 2):S102-103.
12. Malaviya R, Uckun FM. Histamine as an autocrine regulator of leukemic cell proliferation. Leuk Lymphoma 2000, 36:367-373.
13. Garcia-Caballero M, Neugebauer E, Campos R, Nunez de Castro I, Vara-Thorbeck C. Increased histidine decarboxylase (HDC) activity in human colorectal cancer: results of a study on ten patients. Agents Actions 1988, 23:357-360.
14. Reynolds JL, Akhter J, Adams WJ, Morris DL. Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function?. Eur J Surg Oncol 1997, 23:224-227.
15. Backhaus B, Weidenhiller M, Bijlsma P, Hahn EG, Raithel M. Evaluation of spontaneous histamine release from colorectal mucosa in patients with colorectal adenoma, patients with gastrointestinally mediated allergy and in a healthy control group. Inflamm Res 2004, 53(Suppl 1):S87-88.
16. Nielsen HJ, Hammer JH, Moesgaard F, Kehlet H. Possible role of histamine-2 receptor antagonists for adjuvant treatment in colorectal cancer. Clinical review. Eur J Surg 1991, 157:437-441.
17. Petit-Bertron AF, Machavoine F, Defresne MP, Gillard M, Chatelain P, Mistry P, Schneider E, Dy M. H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cells. PLoS One 2009, 4:e6504.
18. Medina V, Croci M, Crescenti E, Mohamad N, Sanchez-Jimenez F, Massari N, Nunez M, Cricco G, Martin G, Bergoc R, Rivera E. The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. Cancer Biol Ther 2008, 7:28-35.
19. Cricco GP, Mohamad NA, Sambuco LA, Genre F, Croci M, Gutierrez AS, Medina VA, Bergoc RM, Rivera ES, Martin GA. Histamine regulates pancreatic carcinoma cell growth through H3 and H4 receptors. Inflamm Res 2008, 57(Suppl 1):S23-24.
20. Sander LE, Lorentz A, Sellge G, Coeffier M, Neipp M, Veres T, Frieling T, Meier PN, Manns MP, Bischoff SC. Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. Gut 2006, 55:498-504.
21. Boer K, Helinger E, Helinger A, Pocza P, Pos Z, Demeter P, Baranyai Z, Dede K, Darvas Z, Falus A. Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine. Eur J Cell Biol 2008, 87:227-236.
22. Cianchi F, Cortesini C, Schiavone N, Perna F, Magnelli L, Fanti E, Bani D, Messerini L, Fabbroni V, Perigli G, et al. The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin Cancer Res 2005, 11:6807-6815.
23. Demicheli R, Foroni R, Ingrosso A, Pratesi G, Soranzo C, Tortoreto M. An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data. Cancer Res 1989, 49:6543-6546.
24. Quinn LA, Moore GE, Morgan RT, Woods LK. Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res 1979, 39:4914-4924.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
26. Chen Y, Liu H, Liu Z, Liang S, Chen J, Long F, Peng Y, Yan L, Gong J. Blockade of inducible costimulator pathway to prevent acute rejection in rat liver transplantation. Am J Surg 2009, 198:244-249.
27. Buckland KF, Williams TJ, Conroy DM. Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor. Br J Pharmacol 2003, 140:1117-1127.
28. Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003, 305:1212-1221.
29. Sugata Y, Okano M, Fujiwara T, Matsumoto R, Hattori H, Yamamoto M, Nishibori M, Nishizaki K. Histamine H4 receptor agonists have more activities than H4 agonism in antigen-specific human T-cell responses. Immunology 2007, 121:266-275.
30. Matsuda N, Teramae H, Futatsugi M, Takano K, Yamamoto S, Tomita K, Suzuki T, Yokoo H, Koike K, Hattori Y. Up-regulation of histamine H4 receptors contributes to splenic apoptosis in septic mice: counteraction of the antiapoptotic action of nuclear factor-kappaB. J Pharmacol Exp Ther 332:730-737.
31. Werner JM, Eger K, Jurgen Steinfelder H. Comparison of the rapid pro-apoptotic effect of trans-beta-nitrostyrenes with delayed apoptosis induced by the standard agent 5-fluorouracil in colon cancer cells. Apoptosis 2007, 12:235-246.
32. Backus HH, Pinedo HM, Wouters D, Kuiper CM, Jansen G, van Groeningen CJ, Peters GJ. Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolates. Oncol Res 2000, 12:231-239.
33. Cheng JD, Werness BA, Babb JS, Meropol NJ. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma. Clin Cancer Res 1999, 5:1057-1062.
34. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 13:1501-1512.
35. Cam WR, Masaki T, Shiratori TY, Kato N, Okamoto M, Yamaji Y, Igarashi K, Sano T, Omata M. Activation of cyclin E-dependent kinase activity in colorectal cancer. Dig Dis Sci 2001, 46:2187-2198.
36. McKay JA, Douglas JJ, Ross VG, Curran S, Ahmed FY, Loane JF, Murray GI, McLeod HL. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. Clin Cancer Res 2000, 6:1113-1118.
37. Rao S, Gray-Bablin J, Herliczek TW, Keyomarsi K. The biphasic induction of p21 and p27 in breast cancer cells by modulators of cAMP is posttranscriptionally regulated and independent of the PKA pathway. Exp Cell Res 1999, 252:211-223.